Yep, nice summary.
Although this is a set-back for share holders, I'm certainly not overly disapointed. The project is exceptionally robust and the return will be huge. EQN are being VERY conservative in everthing they do. No provision for Cobalt or Uranium credits (credits? - Uranium is going be worth a LOT of $$$ to EQN). Big possibility of capital costs coming in lower than they've just disclosed.
I doubt they'll have ANY trouble raising the extra debt required for the finance - and I don't think it'll involve excessive hedging either.
They can always recover some costs over the next 2 years by spinning off their Uranium assets - that would attract a significant number of investing dollars, however I'd prefer they developed this themselves as it would diversify them away from Copper a little.
The wave of frustration caused by yesterday's announcement will be long forgotten when EQN are upwards of $6 and pulling in over a billion USD in profit per year from 2008.
Persuader
- Forums
- ASX - By Stock
- EQN
- project status
EQN
equinox resources limited.
Add to My Watchlist
1.27%
!
7.8¢

project status, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.8¢ |
Change
-0.001(1.27%) |
Mkt cap ! $12.07M |
Open | High | Low | Value | Volume |
7.8¢ | 7.8¢ | 7.8¢ | $1.089K | 13.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 12374 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 0.077 |
1 | 7500 | 0.076 |
4 | 122334 | 0.075 |
1 | 150000 | 0.074 |
1 | 13698 | 0.073 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 60526 | 1 |
0.083 | 50000 | 1 |
0.084 | 25000 | 1 |
0.085 | 185000 | 2 |
0.086 | 104600 | 2 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EQN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online